[Skip to content]

tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load tab rollover pre-load
Monday 27 September 2021
Salford GP Header Montage
Latest News:
RSS icon
Medicine, tablets, pills


This is an electronic version of our Formulary written in conjunction with the Medicine Management Committee and the Pharmacy department.   The purpose of the Formulary is:

  • To promote safe, rational and cost effective prescribing within the Trust.
  • To help select the most appropriate drug amongst the many available.


This formulary is intended to act as a rapid reference source.  It is intended for the guidance of medical practitioners, nurses and other healthcare workers.


For local GPs and Non-medical prescribers working in the community there is the Greater Manchester Joint Formulary produced by the Greater Manchester Medicines Management Group (GMMMG).  The formulary ensures that patients receive seamless care across the primary-secondary care interface and reduces the need for switching programmes. All medicines recommended for use in the NHS in a NICE Technology Assessment (TA) are approved for use in Greater Manchester, the GMMMG site provides a list of medicines with a positive recommendation from  NICE and provides links to these TAs in the GMMMG formulary.  In the SRFT formulary below all the drugs with a positive NICE TA that are applicable to SRFT are included in the formulary.


How to use

All medicines are listed alphabetically using the generic name where possible.  Some brand names are used.


  1. Type the drug name in the 'Keywords' box

  2. Click on the 'Search' button

  3. Within the results, click on the 'generic name' of the medicine you are looking for.

  4. Click on the 'Link' - this will take you to further information that talks about that medicine. 



Drug NameBNF CategoryComment / Usage RestrictionsDetails
Dabigatran2.8.2 Oral anticoagulantsApproved for use in line with GMMMG protocol. Also see attached documents for more details. 
Dabigatran2.8.2 Oral anticoagulantsAn option for stroke prevention in non valvular AF -Approved for use in line with NICE and GMMMG protocol. Also see attached documents for more details. NICE guidance exists for VTE prevention post hop and knee surgery . Trust choice is rivaroxaban post hip and kneee surgery but other options would be considered under IFR request system if rivaroxaban not approriate.Prescriber Decision Support - NOACS
Dabigatran2.8.2 Oral anticoagulantsApproved for use in patients who are already on dabigatran and require cardioversion (off license).  Cardioversion in patients on other new oral anticoagulant drugs (e..g rivaroxaban, apixaban)  will be at the discretion of the treating consultant. Prescriber Decision Support - NOACS
DabigatranSee online BNFApproved March 2013 for use in patients with non-valvular AF due to undergo DC cardioversion as instructed by Cardiology Consultant  
Daclizumab, Zinbryta®, BiogenSee online BNFFor the treatment of adult patients with relapsing forms of multiple sclerosis (MS) As per NICE TA 441 https://www.nice.org.uk/guidance/ta441Approved May 2017  
Danaparoid2.8.1 HeparinoidsHaematology recommendation only 
Danazol6.7.2 Drugs affecting gonadotrophins  
Dansac Soft Paste1.8 Stoma Care - contact Stoma Care Specialist for advice  
Dantrolene Sodium10.2.2 Skeletal muscle relaxants  
Dantrolene Sodium15.1.6 Anticholinesterases used in anaesthesia  


All material in this section is aimed at health professionals, but is information currently held within the public domain.   Members of the public seeking advice on medicine-related matters are encouraged to speak with their GP, pharmacist or nurse, or contact NHS Direct on 0845 46 47.